Glimepiride + Metformin + Voglibose
AntidiabeticUses of Glimepiride + Metformin + Voglibose
- Glimepiride + Metformin + Voglibose is used as third-line therapy for Type II diabetes mellitus in adult patients.
- This approach is recommended when glycemic control remains inadequate despite dietary measures, exercise, and previous interventions involving single agents or second-line therapy with two medications.
Side effects of Glimepiride + Metformin + Voglibose
- Nausea
- Diarrhoea
- Abdominal pain
- Constipation
- Vomiting
- Metallic taste
- Headache
- Dizziness
How Glimepiride + Metformin + Voglibose works
- The principal mechanism by which glimepiride lowers blood glucose levels is believed to rely on stimulating insulin release from functional pancreatic beta cells. Furthermore, the activity of sulfonylureas, including glimepiride, may involve extrapancreatic effects.
- Metformin exerts its effects through multiple mechanisms, including the reduction of hepatic glucose production, inhibition of intestinal glucose absorption, and enhancement of insulin sensitivity through increased peripheral glucose uptake and utilisation. Significantly, compared to sulfonylureas (SUs), metformin does not induce hypoglycemia.
- Voglibose (alpha-glucosidase inhibitor) is a synthetic compound exhibiting robust and sustained therapeutic effects against complications affecting the sensory, motor, and autonomic nerve systems associated with diabetes mellitus. As part of the class of oral anti-diabetic drugs known as alpha-glucosidase inhibitors, Voglibose is employed explicitly for diabetes mellitus type 2. Its mechanism of action involves the prevention of the digestion of complex carbohydrates, like starch, within the gastrointestinal tract. Normally, complex carbohydrates undergo conversion into simple sugars (monosaccharides), which are then absorbed through the intestine. By inhibiting the activity of alpha-glucosidase, Voglibose mitigates the impact of complex carbohydrates on blood sugar levels, contributing to glycemic control in individuals with diabetes mellitus type 2.
Certified content
Written By
B. Pharm
Reviewed By
B. Pharm, MSc.
Expert Advice
Dosage Forms Available
- Glimepiride + Metformin + Voglibose is available for use via the oral route (tablets).
Age and Dose Restrictions
- This combination is meant for use in adults and children above 18 years of age.
Contraindications
- Glimepiride + Metformin + Voglibose is CONTRAINDICATED in patients with severe hepatic dysfunction, metabolic acidosis, and heart issues.
Other Medications To Avoid With This Medicine
- The concurrent use of medications, including those prescribed for heart failure (digoxin), high blood pressure (hydrochlorothiazide, amlodipine), diuretics (furosemide), hypertension (metoprolol), steroids (prednisolone), and thyroid hormones, alongside Glimepiride + Metformin + Voglibose is not recommended. Prior consultation with a doctor is crucial before considering the use of any prescription or over-the-counter medications to ensure the safety and efficacy of the combined treatment plan.
Overdose and Missed Dose
- Overdose of this combination can cause hypoglycemia. Inform your doctor regarding these effects and follow the advice accordingly.
- If you forget a dose of this combination, take it as soon as you remember. But avoid repeating the dose.
Use In Driving And Operating Machinery
- This combination does not directly impact your ability to drive or operate machinery. However, they may lead to hypoglycemia which can cause dizziness. Taking precautions to prevent low blood sugar while driving or handling machinery is essential.
Use in Pregnancy and Lactation
- Glimepiride + Metformin + Voglibose is not recommended in pregnant and breastfeeding women.
Special Dietary & Lifestyle Recommendation
- Making lifestyle changes, including dietary modifications and regular exercise, is essential when taking Glimepiride + Metformin + Voglibose to control blood sugar levels properly.
- After initiating treatment with Glimepiride + Metformin + Voglibose, it's recommended to have your blood sugar levels reassessed after 15 days and, subsequently, at regular intervals every 3-6 months. This monitoring helps track the progress of the disease and allows for dose adjustments as needed.
- If hypoglycemia occurs, it's essential to have a quick source of sugar readily available. Carry sugar candies, glucose tablets, or sugary foods and drinks without fat or protein, such as fruit juice, to promptly address low blood sugar episodes.
Frequently asked questions
How much does Glimepiride + Metformin + Voglibose take to work?
This combination may start to work within a few hours, but it may take some time to see the full effects. It's important to continue taking it as your doctor prescribes, even if you start feeling better.
What warnings and precautions should I take while taking Glimepiride + Metformin + Voglibose?
While taking this combination, be cautious to avoid hypoglycemia (low blood sugar). Avoid taking it if you are allergic to either of the components of this combination.
Should I stop taking Glimepiride + Metformin + Voglibose if I feel healthy?
Do not stop taking this combination without consulting your doctor, even if you feel healthy. Abruptly discontinuing this medication can lead to uncontrolled blood sugar levels.
Does Glimepiride + Metformin + Voglibose affect fertility?
This combination typically does not affect fertility. However, if you have concerns about fertility and its impact on diabetes management, discuss them with your doctor.
Glimepiride + Metformin + Voglibose in other salts
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v2.5.2
2024 - Truemeds | All rights reservedOur Payment Partners
